Efficacy and safety of probusco combined with atovastatin in treatment of carotid atherosclerotic plaque in very old patients
Received:February 26, 2019  
View Full Text  View/Add Comment  Download reader
DOI:10.11915/j.issn.1671-5403.2019.06.086
Key words:aged, 80 and over; probucol; atorvastatin; carotid atherosclerotic plaque; safety
Author NameAffiliationE-mail
WU Kun Department of Neurology, Beijing Hepingli Hospital, Beijing 100013, China  
LI Bo Department of Neurology, Beijing Hepingli Hospital, Beijing 100013, China 13691089898@139.com 
ZHANG Xuan Department of Neurology, Beijing Hepingli Hospital, Beijing 100013, China  
WANG Li Department of Neurology, Beijing Hepingli Hospital, Beijing 100013, China  
WANG Lin Department of Neurology, Beijing Hepingli Hospital, Beijing 100013, China  
LIU Wei Department of Neurology, Beijing Hepingli Hospital, Beijing 100013, China  
LI Xing Department of Neurology, Beijing Hepingli Hospital, Beijing 100013, China  
Hits: 252
Download times: 235
Abstract:
      Objective To investigate the clinical efficacy and safety of probucol combined with atorvastatin in treatment of carotid atherosclerotic plaque in very old patients. Methods Sixty very old patients (≥80 years old) with carotid atherosclerotic plaques identified by ultrasonography admitted in our department from January 2017 to December 2017 were recruited in this study, and then randomly divided into control group (n=30) and combined treatment group (n=30). Both groups of patients were given oral administration of atorvastatin, while those from the combined treatment group were treated with combination of probucol. The related clinical indices were recorded before and after 36 weeks′ treatment. SPSS statistics 19.0 was used to perform the statistical analysis. Chi-square test or Student′s t test was employed for comparison between the 2 groups based on different data types. Results The combined treatment group had significantly lower serum total cholesterol [(3.42±1.63) vs (3.83±1.34)mmol/L], triglycerides [(1.80±1.37) vs (1.95±1.65)mmol/L], low-density lipoprotein cholesterol [(2.13±1.32) vs (2.63±1.64)mmol/L], neuronal specific enolase [(9.48±6.78) vs (12.31±9.78)mmol/L] and high-sensitivity C-reactive protein [(3.42±1.36) vs (4.56±3.36)mmol/L], but obviously higher high-density lipoprotein cholesterol [(1.64±1.01) vs (1.43±1.12)mmol/L] when compared with the control group (all P<0.05). There was no significant differences in all indices concerning safety before and after treatment in the both groups (P>0.05). Conclusion Probucol combined with atorvastatin effectively improves the resistance indices of carotid artery in very old patients, and shows obvious protective effects on oxidation damage and nerve damage with good clinical safety.
Close